Home > News > Labopharm reports results for third quarter fiscal 2004
October 28th, 2004
Labopharm reports results for third quarter fiscal 2004
Abstract:
Labopharm Inc. (TSX: DDS) today reported its results for the third quarter of fiscal 2004 ended
September 30, 2004. Net loss for the third quarter of fiscal 2004 was $5.9 million, or $0.14
per share, compared with $7.9 million, or $0.22 per share, for the third quarter of fiscal 2003.
Source:
prnewswire
Bookmark:
| Related Links |
| Related News Press |
Announcements
Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026
COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||